Bollard CM - Search Results

1

Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant.

Weber G, Gerdemann U, Caruana I, Savoldo B, Hensel NF, Rabin KR, Shpall EJ, Melenhorst JJ, Leen AM, Barrett AJ, Bollard CM. Weber G, et al. Among authors: bollard cm. Leukemia. 2013 Jul;27(7):1538-47. doi: 10.1038/leu.2013.66. Epub 2013 Mar 1. Leukemia. 2013. PMID: 23528871 Free PMC article.

2

Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease.

Bollard CM, Savoldo B, Rooney CM, Heslop HE. Bollard CM, et al. Acta Haematol. 2003;110(2-3):139-48. doi: 10.1159/000072463. Acta Haematol. 2003. PMID: 14583674 Review.

3

Adoptive immunotherapy for posttransplantation viral infections.

Bollard CM, Kuehnle I, Leen A, Rooney CM, Heslop HE. Bollard CM, et al. Biol Blood Marrow Transplant. 2004 Mar;10(3):143-55. doi: 10.1016/j.bbmt.2003.09.017. Biol Blood Marrow Transplant. 2004. PMID: 14993880 Free article. Review.

4

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease.

Bollard CM, Straathof KC, Huls MH, Leen A, Lacuesta K, Davis A, Gottschalk S, Brenner MK, Heslop HE, Rooney CM. Bollard CM, et al. J Immunother. 2004 Jul-Aug;27(4):317-27. doi: 10.1097/00002371-200407000-00008. J Immunother. 2004. PMID: 15235393

5

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.

Straathof KC, Leen AM, Buza EL, Taylor G, Huls MH, Heslop HE, Rooney CM, Bollard CM. Straathof KC, et al. Among authors: bollard cm. J Immunol. 2005 Sep 15;175(6):4137-47. doi: 10.4049/jimmunol.175.6.4137. J Immunol. 2005. PMID: 16148164

6

Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab.

Lamba R, Carrum G, Myers GD, Bollard CM, Krance RA, Heslop HE, Brenner MK, Popat U. Lamba R, et al. Among authors: bollard cm. Bone Marrow Transplant. 2005 Nov;36(9):797-802. doi: 10.1038/sj.bmt.1705121. Bone Marrow Transplant. 2005. PMID: 16151431

7

T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients.

Leen AM, Myers GD, Bollard CM, Huls MH, Sili U, Gee AP, Heslop HE, Rooney CM. Leen AM, et al. Among authors: bollard cm. Ann N Y Acad Sci. 2005 Dec;1062:104-15. doi: 10.1196/annals.1358.013. Ann N Y Acad Sci. 2005. PMID: 16461793 Review.

8

Adenoviral infections in hematopoietic stem cell transplantation.

Leen AM, Bollard CM, Myers GD, Rooney CM. Leen AM, et al. Among authors: bollard cm. Biol Blood Marrow Transplant. 2006 Mar;12(3):243-51. doi: 10.1016/j.bbmt.2005.10.024. Biol Blood Marrow Transplant. 2006. PMID: 16503493 Free article. Review.

9

In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.

Bollard CM, Gottschalk S, Huls MH, Molldrem J, Przepiorka D, Rooney CM, Heslop HE. Bollard CM, et al. Leuk Lymphoma. 2006 May;47(5):837-42. doi: 10.1080/10428190600604724. Leuk Lymphoma. 2006. PMID: 16753867

10

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

Leen AM, Myers GD, Sili U, Huls MH, Weiss H, Leung KS, Carrum G, Krance RA, Chang CC, Molldrem JJ, Gee AP, Brenner MK, Heslop HE, Rooney CM, Bollard CM. Leen AM, et al. Among authors: bollard cm. Nat Med. 2006 Oct;12(10):1160-6. doi: 10.1038/nm1475. Epub 2006 Sep 24. Nat Med. 2006. PMID: 16998485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters